Life sciences investment firm Emergent Medical Partners seeks $50m for second VC fund

Life sciences early-stage investor Emergent Medical Partners is on the road for its Emergent Medical Partners II fund with a target of $50m having already raised $37m, according to a filing with the US Securities and Exchange Commission. The firm, led by cardiovascular surgeon Thomas Fogarty and life sciences veteran entrepreneur Allan May, focuses on …